Patients often regain some weight after stopping a GLP-1, but your clinician will help you set realistic expectations and find a plan that works for you
Does the MAPK/ERK pathway activation by GLP-1 agonists have a net positive or negative effect on follicular health
The company is predicting slower growth in 2025 because of the impact of the Inflation Reduction Act redesign of Medicare Part D, in which three of the first 10 drugs up for price negotiation are J&J drugs
Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, et al
Popular GLP-1 drug brands include Ozempic, Zepbound, and Mounjaro
Other supporters, including physicians and industry leaders, argued the fast-growing med spa market operates like the Wild, Wild West and poses patient safety risks